| Design and synthesis of novel xanthone-triazole derivatives as potential antidiabetic agents: α-Glucosidase inhibition and glucose uptake promotion GJ Ye, T Lan, ZX Huang, XN Cheng, CY Cai, SM Ding, ML Xie, B Wang European Journal of Medicinal Chemistry 177, 362-373, 2019 | 87 | 2019 |
| Novel oxazolxanthone derivatives as a new type of α-glucosidase inhibitor: synthesis, activities, inhibitory modes and synergetic effect SM Ding, T Lan, GJ Ye, JJ Huang, Y Hu, YR Zhu, B Wang Bioorganic & Medicinal Chemistry 26 (12), 3370-3378, 2018 | 29 | 2018 |
| Blocking bacterial naphthohydroquinone oxidation and ADP-ribosylation improves activity of rifamycins against Mycobacterium abscessus US Ganapathy, T Lan, P Krastel, M Lindman, MD Zimmerman, HP Ho, ... Antimicrobial agents and chemotherapy 65 (9), 10.1128/aac. 00978-21, 2021 | 15 | 2021 |
| Redesign of Rifamycin Antibiotics to Overcome ADP‐Ribosylation‐Mediated Resistance T Lan, US Ganapathy, S Sharma, YM Ahn, M Zimmerman, V Molodtsov, ... Angewandte Chemie 134 (45), e202211498, 2022 | 11 | 2022 |
| Xanthone sulfonamide derivatives-A novel series of α-glucosidase inhibitors with different inhibitory types WD Duan, JY Cao, CY Cai, ZR Yang, JF Cui, T Lan, YN Chen, J Wang, ... Journal of Molecular Structure 1263, 133026, 2022 | 4 | 2022 |
| Blocking ADP-ribosylation expands the anti-mycobacterial spectrum of rifamycins US Ganapathy, T Lan, V Dartois, CC Aldrich, T Dick Microbiology Spectrum 11 (5), e01900-23, 2023 | 3 | 2023 |
| Amycolatopsis mediterranei: A Sixty-Year Journey from Strain Isolation to Unlocking Its Potential of Rifamycin Analogue Production by Combinatorial Biosynthesis U Sood, M Müller, T Lan, G Garg, N Singhvi, P Hira, P Singh, A Nigam, ... Journal of Natural Products, 2024 | | 2024 |
| ADP-ribosylation-resistant rifabutin analogs show improved bactericidal activity against drug-tolerant M. abscessus in caseum surrogate M Xie, US Ganapathy, T Lan, P Osiecki, JP Sarathy, V Dartois, CC Aldrich, ... Antimicrobial agents and chemotherapy 67 (9), e00381-23, 2023 | | 2023 |
